Immunovant (IMVT) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free IMVT Stock Alerts $27.17 -0.58 (-2.09%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineImmunovant, Inc. (NASDAQ:IMVT) Insider Sells $94,242.90 in Stockmarketbeat.com - April 26 at 8:04 PMabrdn plc Makes New $13.81 Million Investment in Immunovant, Inc. (NASDAQ:IMVT)marketbeat.com - April 26 at 6:13 AMShould You Hold Immunovant (IMVT)?finance.yahoo.com - April 24 at 12:06 PMAllspring Global Investments Holdings LLC Acquires 36,659 Shares of Immunovant, Inc. (NASDAQ:IMVT)marketbeat.com - April 23 at 4:33 AMBuy Rating Affirmed for Immunovant on Strong Drug Development Prospects and Efficacy Confidencemarkets.businessinsider.com - April 22 at 5:52 PMJulia G. Butchko Sells 10,115 Shares of Immunovant, Inc. (NASDAQ:IMVT) Stockinsidertrades.com - April 21 at 6:28 AMEva Renee Barnett Sells 12,253 Shares of Immunovant, Inc. (NASDAQ:IMVT) Stockamericanbankingnews.com - April 21 at 5:44 AMPeter Salzmann Sells 34,079 Shares of Immunovant, Inc. (NASDAQ:IMVT) Stockamericanbankingnews.com - April 21 at 4:32 AMImmunovant CFO sells shares worth over $350kinvesting.com - April 20 at 7:50 PMImmunovant, Inc. (NASDAQ:IMVT) Insider Sells $293,941.90 in Stockmarketbeat.com - April 19 at 6:44 PMImmunovant (NASDAQ:IMVT) Trading Down 3.6%marketbeat.com - April 17 at 11:58 AMImmunovant, Inc. (IMVT) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - April 16 at 11:45 PMWCM Investment Management LLC Takes $4.55 Million Position in Immunovant, Inc. (NASDAQ:IMVT)marketbeat.com - April 15 at 7:20 AMImmunovant is Now Oversold (IMVT)nasdaq.com - April 15 at 12:05 AMImmunovant CEO sells over $149,000 in company stockinvesting.com - April 12 at 7:12 PMImmunovant, Inc. (NASDAQ:IMVT) Expected to Post Q1 2026 Earnings of ($0.49) Per Sharemarketbeat.com - April 11 at 7:58 AMImmunovant, Inc. (NASDAQ:IMVT) Insider Julia G. Butchko Sells 1,053 Sharesinsidertrades.com - April 11 at 6:48 AMJulia G. Butchko Sells 1,053 Shares of Immunovant, Inc. (NASDAQ:IMVT) Stockmarketbeat.com - April 10 at 6:42 PMImmunovant (NASDAQ:IMVT) Stock Price Down 2.8%marketbeat.com - April 8 at 11:59 AMImmunovant: Strategic Edge In The Autoimmune Sector (Rating Upgrade)seekingalpha.com - April 4 at 2:12 AMImmunovant, Inc. (NASDAQ:IMVT) Sees Significant Increase in Short Interestmarketbeat.com - April 2 at 6:55 AM121,268 Shares in Immunovant, Inc. (NASDAQ:IMVT) Acquired by Assenagon Asset Management S.A.marketbeat.com - April 1 at 4:43 AMSG Americas Securities LLC Reduces Stake in Immunovant, Inc. (NASDAQ:IMVT)marketbeat.com - March 30 at 4:25 AMWellington Management Group LLP Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT)marketbeat.com - March 26 at 4:16 AMWall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Richinvestorplace.com - March 25 at 3:00 PMImmunovant (NASDAQ:IMVT) Given "Buy" Rating at Truist Financialmarketbeat.com - March 25 at 1:10 PMBuy Rating for Immunovant Amidst Strong Market Position and Promising Batoclimab Trialsmarkets.businessinsider.com - March 22 at 12:50 AMImmunovant (NASDAQ:IMVT) Shares Gap Up to $31.57marketbeat.com - March 21 at 3:14 PMCitigroup Inc. Buys 38,179 Shares of Immunovant, Inc. (NASDAQ:IMVT)marketbeat.com - March 16 at 5:43 AMImmunovant (NASDAQ:IMVT) Shares Gap Up to $31.50marketbeat.com - March 13 at 12:55 PMImmunovant (NASDAQ:IMVT) Earns Buy Rating from Analysts at The Goldman Sachs Groupmarketbeat.com - March 13 at 8:17 AMImmunovant Inc.: Immunovant Awarded U.S. Patent for IMVT-1402finanznachrichten.de - March 12 at 9:39 AMImmunovant Awarded U.S. Patent for IMVT-1402globenewswire.com - March 12 at 7:30 AMIMVT Jul 2024 30.000 callfinance.yahoo.com - March 11 at 7:37 PMIMVT Mar 2024 40.000 callfinance.yahoo.com - March 11 at 9:35 AMImmunovant, Inc. (NASDAQ:IMVT) is Alpine Global Management LLC's 3rd Largest Positionmarketbeat.com - March 11 at 5:32 AMIMVT Mar 2024 32.000 callfinance.yahoo.com - March 10 at 11:53 PMIMVT Apr 2024 45.000 putfinance.yahoo.com - March 10 at 6:53 PMIMVT Jan 2025 12.500 putfinance.yahoo.com - March 10 at 6:53 PMIMVT Mar 2024 29.000 putfinance.yahoo.com - March 10 at 8:53 AMIMVT Mar 2024 37.500 putfinance.yahoo.com - March 9 at 2:07 PMIMVT Mar 2024 37.000 callfinance.yahoo.com - March 9 at 2:07 PMAdage Capital Partners GP L.L.C. Takes $16.68 Million Position in Immunovant, Inc. (NASDAQ:IMVT)marketbeat.com - March 8 at 7:27 AMFY2024 EPS Estimates for Immunovant, Inc. Increased by Zacks Research (NASDAQ:IMVT)marketbeat.com - March 7 at 7:23 AMIMVT Mar 2024 32.000 putfinance.yahoo.com - March 6 at 10:18 PMIMVT Mar 2024 33.000 putfinance.yahoo.com - March 5 at 7:57 AMIMVT Mar 2024 36.000 callfinance.yahoo.com - March 1 at 11:35 PM77,806 Shares in Immunovant, Inc. (NASDAQ:IMVT) Acquired by Trexquant Investment LPmarketbeat.com - March 1 at 6:48 AMAWM Investment Company Inc. Purchases New Position in Immunovant, Inc. (NASDAQ:IMVT)marketbeat.com - February 29 at 1:00 PMAvidity Partners Management LP Sells 911,338 Shares of Immunovant, Inc. (NASDAQ:IMVT)marketbeat.com - February 27 at 4:24 PM Get Immunovant News Delivered to You Automatically Sign up to receive the latest news and ratings for IMVT and its competitors with MarketBeat's FREE daily newsletter. Email Address The Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you. 4 simple steps to protect your privacy and money before it’s too late. IMVT Media Mentions By Week IMVT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMVT News Sentiment▼0.530.32▲Average Medical News Sentiment IMVT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMVT Articles This Week▼134▲IMVT Articles Average Week Get Immunovant News Delivered to You Automatically Sign up to receive the latest news and ratings for IMVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KRYS News Today HALO News Today CRSP News Today IBRX News Today IOVA News Today SWTX News Today APGE News Today ACLX News Today RVMD News Today IMCR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMVT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
